Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/48482
DC FieldValueLanguage
dc.contributor.authorBjerrum, Larsen_US
dc.contributor.authorGonzález Lopez-Valcarcel, Beatrizen_US
dc.contributor.authorPetersen, Gerten_US
dc.date.accessioned2018-11-23T22:12:14Z-
dc.date.available2018-11-23T22:12:14Z-
dc.date.issued2008en_US
dc.identifier.issn1381-4788en_US
dc.identifier.urihttp://hdl.handle.net/10553/48482-
dc.description.abstractObjective: To identify patient- and practice-related factors associated with potential drug interactions. Methods: A register analysis study ingeneral practices in the county of Funen, Denmark. Prescription data were retrieved from a population-based prescription database (Odense University Pharmacoepidemiologic Database, OPED) covering prescriptions to all inhabitants in the county of Funen, Denmark. All individuals exposed to concurrent use of two or more drugs (polypharmacy) were identified. Combinations of drugs with potential interactions were registered and classified as major, moderate, or minor, depending on the severity of outcome and the quality of documentation. A two-level random coefficient logistic regression model was used to investigate factors related to potential drug interactions. Results: One-third of the population was exposed to polypharmacy, and 6% were exposed to potential drug interactions during 1 year. Patient factors associated with increased risk of potential drug interactions were high age, a high number of concurrently used drugs, and a high number of prescribers. Practice factors associated with potential drug interactions were a high percentage of elderly patients and a low percentage of female patients listed. Conclusion: Prescription data maybe useful in quality-improvement programmes to identify groups of patients and practices at increased risk of drug interactions.en_US
dc.languageengen_US
dc.publisher1381-4788
dc.relation.ispartofEuropean Journal of General Practiceen_US
dc.sourceEuropean Journal of General Practice[ISSN 1381-4788],v. 14, p. 23-29en_US
dc.subject.otherDrogasen_US
dc.subject.otherSistema sanitario españolen_US
dc.titleRisk factors for potential drug interactions in general practiceen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1080/13814780701815116
dc.identifier.scopus47149107043-
dc.contributor.authorscopusid7006017468-
dc.contributor.authorscopusid6507677112-
dc.contributor.authorscopusid7202922868-
dc.description.lastpage29-
dc.description.firstpage23-
dc.relation.volume14-
dc.investigacionCiencias Sociales y Jurídicasen_US
dc.type2Artículoen_US
dc.utils.revisionen_US
dc.date.coverdateJulio 2008
dc.identifier.ulpgces
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR Economía de la salud y políticas públicas-
crisitem.author.deptDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.orcid0000-0002-5571-3257-
crisitem.author.parentorgDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.fullNameGonzález Lopez-Valcarcel, Beatriz-
Appears in Collections:Artículos
Thumbnail
Adobe PDF (344,55 kB)
Show simple item record

SCOPUSTM   
Citations

61
checked on Dec 15, 2024

Page view(s)

109
checked on Nov 1, 2024

Download(s)

145
checked on Nov 1, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.